NCT05168904 2024-02-08A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)Cyclacel Pharmaceuticals, Inc.Phase 1/2 Suspended210 enrolled
NCT01211691 2015-11-17Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)Humanigen, Inc.Phase 1/2 Suspended120 enrolled